Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966672 | PMC |
http://dx.doi.org/10.1155/2018/4606491 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!